Pfizer Appeals Viagra Ruling In China

Law360, New York (February 6, 2007, 12:00 AM EST) -- After suffering a blow in its bid to protect the rights to Viagra in China, Pfizer Inc. is appealing a Beijing court ruling that the drug maker can no longer use the name Wei Ge, or “mighty brother,” to market its erectile dysfunction drug.

Pfizer said on Tuesday that it filed its appeal in the Beijing No. 1 Intermediate People's Court on Jan. 30.

The company said the ruling “fails to support Chinese efforts to create an environment of innovation that provides consistent protection of intellectual...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.